Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Paul Maier Insider Profile

4 Followers

Paul Maier, Director at International Stem Cell, holds 0.00 shares in International Stem Cell (Ticker: ISCO), holds 59.74K shares in Eton Pharmaceuticals (Ticker: ETON), holds 85.00K shares in Ambrx Biopharma (Ticker: AMAM). Most recently, Paul Maier Sold ― shares of International Stem Cell on Sep 15, 2026 for an estimated value of $10.50K.

Paul Maier's Trading History

ISCOInternational Stem Cell		Sep 15, 2026DirectorInformative Sell10.50K$0.00
ETONEton Pharmaceuticals		Aug 28, 2026DirectorUninformative Buy189.00K$3.12M
AMAMAmbrx Biopharma		Jun 09, 2023―Uninformative Buy―$2.38M
MBVXQMabVax Therapeutics Holdings		Jan 24, 2018―Uninformative Sell30.30K$539.63
SEELQSeelos Therapeutics		Jan 06, 2017DirectorUninformative Buy――
SQNMSequenom		Feb 12, 2014―Uninformative Buy―$176.36K
TLONTalon Therapeutics Inc		Jul 18, 2013―Uninformative Sell――
PUREPure Bioscience		Aug 02, 2012DirectorUninformative Buy5.21K$5.11K
LGNDLigand Pharma		―Sr. V-P, CFO―$27.42M
FFRFF EAI Robotics Ecosystem Inc		―Director―$0.00
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Paul Maier insider profile FAQ

What is the percentage of profitable transactions made by Paul Maier?
The percentage of profitable transactions made by Paul Maier is 75%.
What is the average return per transaction made by Paul Maier?
The average return per transaction made by Paul Maier is 14.30%.
What stocks does Paul Maier hold?
Paul Maier holds: ISCO, SEELQ, ETON, AMAM, MBVXQ, FFR, LGND, SQNM, PURE, TLON stocks.
What was Paul Maier’s latest transaction?
Paul Maier’s latest transaction was an Informative Sell of $10.50K.
What was Paul Maier's most profitable transaction?
Paul Maier’s most profitable transaction was an Informative Sell of ISCO stock on April 22, 2019. The return on the trade was 65.50%.
What is Paul Maier's role in International Stem Cell?
Paul Maier's role in International Stem Cell is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.